Martin Michaelis (he/him)#Evidence that #nirmatrelvir/ #ritonavir (#Paxlovid) is not effective as post-exposure prophylaxis for #COVID19 after #SARSCoV2 infection.
#Evidence that #nirmatrelvir/ #ritonavir (#Paxlovid) is not effective as post-exposure prophylaxis for #COVID19 after #SARSCoV2 infection.